AlinaMarkovaMD
Dermatology • New York, NYAssociate Attending, Clinical Director of Dermatology Service
Dr. Markova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
530 E 74th Street
New York, NY 10021Phone+1 646-608-2342- Is this information wrong?
Education & Training
Boston University Medical CenterResidency, Dermatology, 2013 - 2016
Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2013
The Warren Alpert Medical School of Brown UniversityClass of 2012, MD
Johns Hopkins UniversityBA, Mathematics, 2004 - 2008
Certifications & Licensure
NJ State Medical License 2022 - 2025
NY State Medical License 2016 - 2025
MA State Medical License 2012 - 2016- American Board of Dermatology Dermatology
Clinical Trials
- Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease Start of enrollment: 2019 May 14
- Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies Start of enrollment: 2020 Sep 16
- A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer Start of enrollment: 2021 Dec 15
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohe...> ;Journal for Immunotherapy of Cancer. 2024 Apr 10
- Cutaneous Hypersensitivity Reactions to Immune Checkpoint Inhibitors.Ryan Storgard, Alina Markova> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Mar 26
- Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.Krystel-Whittemore, M., Petrova-Drus, K., Ptashkin, R., Ewalt, M., Yao, J., Liu, Y., Zhu, M., Benhamida, J., Durham, B., Kumar, J., Nafa, K., Kiecka, I., Bowman, A., G...> ;Haematologica. 2024 Mar 7
- Join now to see all
Press Mentions
Are Nail Salon UV Lamps a Skin Cancer Risk?April 30th, 2014
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerFebruary 13th, 2024
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
